[Prognostic value of pulmonary hemodynamic parameters for predicting survival in acute coronary syndrome]

R L Quan1, D A Huang2, L P Pang2

  • 1Department of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medial Sciences and Peking Union Medical College, Beijing 100037, China.

Zhonghua Yi Xue Za Zhi
|October 13, 2022
PubMed

Insights

Pulmonary hemodynamics, including mean pulmonary arterial pressure (mPAP) and diastolic pressure gradient (DPG), significantly predict survival in acute coronary syndrome (ACS) patients. Incorporating these measures improves risk assessment beyond the GRACE score.

Area of Science:

  • Cardiology
  • Pulmonary Hypertension
  • Acute Coronary Syndrome

Background:

  • Acute coronary syndrome (ACS) poses significant mortality risks.
  • Risk stratification in ACS is crucial for patient management.
  • Pulmonary hypertension (PH) is increasingly recognized in left heart disease.

Purpose of the Study:

  • To investigate the prognostic implications of pulmonary hemodynamics in ACS patients.
  • To assess whether hemodynamic parameters enhance existing risk scores for ACS mortality.

Main Methods:

  • Prospective multicenter registry study involving ACS patients undergoing cardiac catheterization.
  • Lasso analysis identified prognostic variables for the GRACE score.
  • Right heart catheterization measured pulmonary arterial pressures (mPAP, sPAP) and DPG.
  • Model performance evaluated with and without hemodynamic parameters.

Main Results:

  • Pulmonary hemodynamics (mPAP, sPAP, DPG) were significant predictors of all-cause mortality in ACS.
  • The Global Registry of Acute Coronary Events (GRACE) score showed moderate predictive ability (C-index 0.703).
  • Adding mPAP or DPG to the GRACE score improved mortality prediction (C-index increased, IDI improved).

Conclusions:

  • Pulmonary hemodynamic parameters offer valuable prognostic information in ACS.
  • These parameters provide incremental value to current risk assessment tools like the GRACE score.
  • Further research into PH in ACS may refine patient stratification and treatment strategies.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
34
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
25
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
189